Skip to main content
Livermore
Livermore
ZHEN

UBS Group AG

SEC CIK
0001610520
Latest filing
Aug 13, 2026

ACIU holding history

AC Immune SA in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ACIU overviewAll 13F holders of ACIUFull Q2 2026 holdings

Shares (Q2 2026)
85,614
Value
$203.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ACIU by UBS Group AG, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202685,614$203.8K<0.1%−16,015−15.8%ReducedHolders
Q1 2026101,629$279.5K<0.1%−92,720−47.7%ReducedHolders
Q4 2025194,349$610.3K<0.1%+177,925+1,083.3%AddedHolders
Q3 202516,424$47.5K<0.1%+8,957+120.0%AddedHolders
Q2 20257,467$15.2K<0.1%−9,221−55.3%ReducedHolders
Q1 202516,688$31.2K<0.1%−32,990−66.4%ReducedHolders
Q4 202449,678$134.1K<0.1%+35,050+239.6%AddedHolders
Q3 202414,628$55.3K<0.1%−1,512−9.4%ReducedHolders
Q2 202416,140$64.4K<0.1%−7,525−31.8%ReducedHolders
Q1 202423,665$70.0K<0.1%−21,335−47.4%ReducedHolders
Q4 202345,000$225.0K<0.1%+2,026+4.7%AddedHolders
Q3 202342,974$122.5K<0.1%+100+0.2%AddedHolders
Q2 202342,874$126.7K<0.1%00.0%UnchangedHolders
Q1 202342,874$100.3K<0.1%00.0%UnchangedHolders
Q4 202242,874$87.5K<0.1%−12,992−23.3%ReducedHolders
Q3 202255,866$176.0K<0.1%+1,041+1.9%AddedHolders
Q2 202254,825$198.0K<0.1%+36,000+191.2%AddedHolders
Q1 202218,825$75.0K<0.1%−73,669−79.6%ReducedHolders
Q4 202192,494$457.0K<0.1%+71,179+333.9%AddedHolders
Q3 202121,315$143.0K<0.1%+20,162+1,748.7%AddedHolders
Q2 20211,153$10.0K<0.1%+328+39.8%AddedHolders
Q1 2021825$6.00K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.